Heneka, M. T.,
Kummer, M. P. &
Innate immune activation in neurodegenerative disease. Nat. Rev.
14, 463–477 (2014)
Lambert, J. C.
et al. Meta-analysis of 74,046 individuals identifies 11 new
susceptibility loci for Alzheimer’s disease. Nat.
45, 1452–1458 (2013)
Yokoyama, J. S.
et al. Association between genetic traits for immune-mediated
diseases and Alzheimer disease. JAMA Neurol.
73, 691–697 (2016)
et al. Conserved epigenomic signals in mice and humans reveal immune
basis of Alzheimer’s disease. Nature
518, 365–369 (2015)
et al. Integrated systems approach identifies genetic nodes and
networks in late-onset Alzheimer’s disease.
153, 707–720 (2013)
et al. Polarization of the effects of autoimmune and
neurodegenerative risk alleles in leukocytes. Science
344, 519–523 (2014)
Karch, C. M.,
Cruchaga, C. &
Goate, A. M.
Alzheimer’s disease genetics: from the bench to the
83, 11–26 (2014)
Musiek, E. S. &
Holtzman, D. M.
Three dimensions of the amyloid hypothesis: time, space and
‘wingmen’. Nat. Neurosci.
18, 800–806 (2015)
Jucker, M. &
Walker, L. C.
Self-propagation of pathogenic protein aggregates in neurodegenerative
501, 45–51 (2013)
Jack, C. R. Jr
et al. Tracking pathophysiological processes in
Alzheimer’s disease: an updated hypothetical model of dynamic
biomarkers. Lancet Neurol.
12, 207–216 (2013)
Heneka, M. T.,
Golenbock, D. T. &
Innate immunity in Alzheimer’s disease. Nat.
16, 229–236 (2015)
Heneka, M. T.
et al. NLRP3 is activated in Alzheimer’s disease and
contributes to pathology in APP/PS1 mice. Nature
493, 674–678 (2013)
et al. Unified polymerization mechanism for the assembly of
ASC-dependent inflammasomes. Cell
156, 1193–1206 (2014)
et al. ASC, a novel 22-kDa protein, aggregates during apoptosis of
human promyelocytic leukemia HL-60 cells. J. Biol. Chem.
274, 33835–33838 (1999)
et al. Prion-like polymerization underlies signal transduction in
antiviral immune defense and inflammasome activation. Cell
156, 1207–1222 (2014)
Franklin, B. S.
et al. The adaptor ASC has extracellular and
‘prionoid’ activities that propagate
inflammation. Nat. Immunol.
15, 727–737 (2014)
et al. The NLRP3 inflammasome is released as a particulate danger
signal that amplifies the inflammatory response. Nat.
15, 738–748 (2014)
Dick, M. S., Sborgi, L., Rühl, S., Hiller, S.
& Broz, P.
ASC filament formation serves as a signal amplification mechanism for
inflammasomes. Nat. Commun.
7, 11929 (2016)
et al. A new amyloid β variant favoring oligomerization
in Alzheimer’s-type dementia. Ann. Neurol.
63, 377–387 (2008)
Borchelt, D. R.
et al. Familial Alzheimer’s disease-linked presenilin 1
variants elevate Aβ1–42/1–40 ratio in
vitro and in vivo. Neuron
17, 1005–1013 (1996)
et al. Secreted amyloid β-protein similar to that in the
senile plaques of Alzheimer’s disease is increased in
vivo by the presenilin 1 and 2 and APP mutations linked to familial
Alzheimer’s disease. Nat. Med.
2, 864–870 (1996)
et al. Canonical Nlrp3 inflammasome links systemic low-grade
inflammation to functional decline in aging. Cell Metab.
18, 519–532 (2013)
et al. Exogenous induction of cerebral β-amyloidogenesis
is governed by agent and host. Science
313, 1781–1784 (2006)
et al. NLRP6 inflammasome regulates colonic microbial ecology and
risk for colitis. Cell
145, 745–757 (2011)
Nuvolone, M., Sorce, S., Schwarz, P.
& Aguzzi, A.
Prion pathogenesis in the absence of NLRP3/ASC inflammasomes.
10, e0117208 (2015)
et al. PPARγ/RXRα-induced and CD36-mediated
microglial amyloid-β phagocytosis results in cognitive
improvement in amyloid precursor protein/presenilin 1 mice. J.
32, 17321–17331 (2012)
Fernandes-Alnemri, T. &
Alnemri, E. S.
Assembly, purification, and assay of the activity of the ASC
pyroptosome. Methods Enzymol.
442, 251–270 (2008)
et al. The pyroptosome: a supramolecular assembly of ASC dimers
mediating inflammatory cell death via caspase-1 activation. Cell
14, 1590–1604 (2007)
et al. GGA1 is expressed in the human brain and affects the
generation of amyloid β-peptide. J. Neurosci.
26, 12838–12846 (2006)
et al. Extracellular phosphorylation of the amyloid
β-peptide promotes formation of toxic aggregates during the
pathogenesis of Alzheimer’s disease. EMBO J.
30, 2255–2265 (2011)
Rostagno, A. &
Isolation and biochemical characterization of amyloid plaques and paired
helical filaments. Curr. Protoc. Cell. Biol.
44, 3.33.1–3.33.33 (2009)
Fritschi, S. K.
et al. Aβ seeds resist inactivation by
formaldehyde. Acta Neuropathol.
128, 477–484 (2014)
Jäger, S. et
al.. α-secretase mediated conversion of the amyloid
precursor protein derived membrane stub C99 to C83 limits Aβ
generation. J. Neurochem.
111, 1369–1382 (2009)